Compounds > zalcitabine
Page last updated: 2024-08-22

zalcitabine and T-Cell Lymphoma

zalcitabine has been researched along with T-Cell Lymphoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Irons, RD; Le, AT; Som, DB; Stillman, WS1
Buckley, LA; Collins, BJ; Foley, JF; Giles, HD; Heath, JE; May, RD; Rao, GN1
Cochran, C; Goodrow, T; Söderkvist, P; Wiseman, RW; Zhuang, SM1
Cinatl, J; Doerr, HW; Driever, PH; Gröschel, B; Kabickova, H; Kornhuber, B; Kotchetkov, R; Schwabe, D1

Other Studies

4 other study(ies) available for zalcitabine and T-Cell Lymphoma

ArticleYear
2'3'-Dideoxycytidine-induced thymic lymphoma correlates with species-specific suppression of a subpopulation of primitive hematopoietic progenitor cells in mouse but not rat or human bone marrow.
    The Journal of clinical investigation, 1995, Volume: 95, Issue:6

    Topics: Adult; Animals; Bone Marrow; Bone Marrow Cells; Colony-Forming Units Assay; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cells; Humans; Interleukin-3; Lymphoma, T-Cell; Male; Mice; Mice, Inbred C57BL; Rats; Recombinant Proteins; Species Specificity; Stem Cell Factor; Thymus Neoplasms; Zalcitabine

1995
Carcinogenicity of 2',3'-dideoxycytidine in mice.
    Cancer research, 1996, Oct-15, Volume: 56, Issue:20

    Topics: Anemia; Animals; Anti-HIV Agents; Atrophy; Body Weight; Carcinogenicity Tests; CD4-CD8 Ratio; Female; Lymphoma, T-Cell; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Sex Factors; Species Specificity; Thymus Gland; Thymus Neoplasms; Time Factors; Tumor Suppressor Protein p53; Zalcitabine

1996
Genetic alterations of p53 and ras genes in 1,3-butadiene- and 2',3'-dideoxycytidine-induced lymphomas.
    Cancer research, 1997, Jul-01, Volume: 57, Issue:13

    Topics: Animals; Blotting, Southern; Butadienes; Carcinogens; Genes, p53; Genes, ras; Lymphoma, T-Cell; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Polymorphism, Single-Stranded Conformational; Zalcitabine

1997
Azidothymidine resistance of H9 human T-cell lymphoma cells is associated with decreased sensitivity to antitumor agents and inhibition of apoptosis.
    International journal of molecular medicine, 1998, Volume: 2, Issue:6

    Topics: Anti-HIV Agents; Antimetabolites; Antineoplastic Agents; Apoptosis; Cytarabine; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, T-Cell; Tumor Cells, Cultured; Zalcitabine; Zidovudine

1998